NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR
MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash | N/A | 748.00M | 879.00M | 1.43B | 1.76B | |||
Cash Equivalents | 2.96B | 2.00B | 3.72B | 4.27B | 6.29B | |||
Marketable Securities | 21.00M | 2.25B | 7.00B | 2.91B | 4.61B | |||
Receivables | 7.78B | 7.40B | 7.12B | 8.03B | 7.26B | |||
Inventories | 5.86B | 5.50B | 5.15B | 5.78B | 6.00B | |||
Other Current Assets | 144.00M | 751.00M | 631.00M | 525.00M | 617.00M | |||
Total Current Assets | 16.76B | 18.64B | 20.77B | 18.67B | 20.25B | |||
Non-Current Assets | ||||||||
PPE Net | 9.82B | 9.96B | 9.62B | 10.67B | 11.01B | |||
Investments And Advances | 1.15B | 1.19B | 1.54B | 2.21B | 3.42B | |||
Goodwill | 6.96B | 6.81B | 7.05B | 10.55B | 10.60B | |||
Intangibles | 15.47B | 14.77B | 14.32B | 30.08B | 29.82B | |||
Other Non-Current Assets | 7.89B | 6.68B | 5.89B | 5.98B | 4.47B | |||
Total Non-Current Assets | 41.30B | 40.36B | 39.38B | 60.43B | 60.18B | |||
TOTAL ASSETS | 58.07B | 59.01B | 60.15B | 79.10B | 80.43B | |||
LIABILITIES | ||||||||
Current Liabilities | ||||||||
Short Term Debt | 0.00 | 1.01B | 1.64B | 802.00M | 1.15B | |||
Current Portion Of LT Debt. | 3.37B | 1.81B | 2.31B | 2.80B | 2.58B | |||
Accrued Expenses | N/A | 10.71B | 10.59B | 11.19B | 9.75B | |||
Accounts Payable | 14.24B | 3.72B | 3.87B | 4.54B | 4.36B | |||
Other Current Liabilities | 2.73B | 3.83B | 4.41B | 4.35B | 4.31B | |||
Total Current Liabilities | 20.34B | 21.07B | 22.81B | 23.67B | 22.15B | |||
Non-Current Liabilities | ||||||||
Long Term Debt | 13.58B | 15.21B | 17.04B | 20.57B | 23.43B | |||
Deferred Taxes/Income | 290.00M | 311.00M | 289.00M | 3.56B | 3.60B | |||
Other Non-Current Liabilities | 10.08B | 9.63B | 9.92B | 9.96B | 10.45B | |||
Total Non-Current Liabilities | 23.35B | 24.59B | 26.74B | 40.38B | 43.70B | |||
TOTAL LIABILITIES | 43.69B | 45.66B | 49.55B | 64.05B | 65.84B | |||
SHAREHOLDERS' EQUITY | ||||||||
Retained Earnings | 9.55B | 9.37B | 6.49B | 10.07B | 8.88B | |||
Additional Paid In Capital | 3.47B | 3.45B | 3.44B | 3.30B | 3.28B | |||
Minority Interest | -602.00M | -552.00M | -502.00M | 6.29B | 6.22B | |||
Common Shares | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | |||
Other Shareholders' Equity | N/A | -310.00M | -373.00M | -49.00M | -226.00M | |||
Shares Outstanding | 2.02B | 2.01B | 2.00B | 1.99B | 1.99B | |||
Tangible Book Value per Share | -1.98 | -2.03 | -2.67 | -6.35 | -6.42 | |||
Total Shareholders' Equity | 14.37B | 13.35B | 10.60B | 15.05B | 14.59B | |||
TOTAL LIABILITIES AND EQUITY | 58.07B | 59.01B | 60.15B | 79.10B | 80.43B | |||
Statistics | ||||||||
Debt/Equity | 0.94 | 1.21 | 1.76 | 1.42 | 1.68 | |||
Current Ratio | 0.82 | 0.88 | 0.91 | 0.79 | 0.91 | |||
Return On Assets (ROA) | 6.95% | 8.35% | 24.87% | 5.54% | 7.15% | |||
Return On Equity (ROE) | 28.06% | 36.92% | 141.12% | 29.13% | 39.41% | |||
Return On Invested Capital (ROIC) | 18.91% | 18.65% | 18.84% | 8.94% | 8.82% | |||
Return On Invested Capital Ex Cash (ROICexc) | 20.54% | 20.94% | 25.99% | 10.25% | 10.81% | |||
Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 57.98% | 55.37% | 106.60% | 59.72% | 64.68% |
All data in GBP , ROIC based on taxRate of 0.13